Company Profile

JSIAMA is a clinical stage company focusing on discovery and development of innovative immunotherapies to treat respiratory diseases including cancers. Through differentiated drug development pathways, we have successfully established a number of promising drug candidates and platforms with global intellectual property rights.
JSIAMA was founded in 2021 by Dr. Liming Liu, an immunologist and 20 plus years R&D executive and former core team member of Keytruda at Merck. We have built a pipeline of multiple innovative drug candidates through technology platforms, including small nucleic acid drug R&D platform, respiratory formulation and delivery platform, and innate super engager (ISE) multi-specific antibody discovery platform.
Customer Service Hotline
Address: 3F, Building E, Phase II, Zhongdan Ecological Life Science Industrial Park, 3-1 Xinjihu Road, Jiangbei New District, Nanjing
Zip Code: 210000
Email: hr@iamabio.com
This website already supports IPV4 / IPV6 bidirectional access
Copyright©2023 Nanjing JSIAMA Biopharmaceutical Co., Ltd.